ResearcherID - CLICK HERE

TITLE:

COMPARISON OF RESULT OF LATERAL AND SURAL SUPRAMALLEOLAR FLAP IN PATIENTS WITH NAKED HEEL AND DISTAL TIBIA FOR COVERAGE OF SOFT TISSUE

AUTHORS:

Dr. Amera Aziz, Dr Monisa Tahir, Dr Ayesha Zafar

ABSTRACT:

Background: For reconstructive surgery, deformities in soft tissue surrounding ankle, is challenging. Objectives: This study aimed at comparison of result of lateral and sural supramalleolar flap in patients with naked heel and distal tibia for coverage of soft tissue. Design of study: It was a comparative cross-sectional study. Duration: Time duration for this study was from 1st March, 2018 to 31ST February, 2019 in Mayo Hospital. Lahore. Patients and Methods: This study was done in orthopedic surgery department, Mayo Hospital. Lahore. There were 32 patients which were divided randomly in two groups A and B. In group A Patients Sural flap was used for coverage of soft tissue deformity. Lateral supramalleous flap was used in group B patients in order to cover the defect. On 5th day after surgery, patients were discharged, suture were removed on 10th days. Later on, these patients were kept followed every 5th day in 2 months. Using SPSS version 12 data was analyzed. RESULT: In group A, mean age of patients was 36 years. In group B, 31 years was mean age. In heel region, 21 patients showed effect in soft tissue while in distal tibia, 11 patients showed deformity. Thauma was major cause of deformity in 30 patients. On the other hand, severe Osteomyelitis was the cause in 2 patients. In group A, flap survival was 100% while in group B, it was 94%. Marginal tissues death happened in 1 and 4 patients of group A and B. wound were cleaned in all patients. In group A and B, flap edema was caused in 2 and 6 patients respectively. Conclusion: Due to reliability and larger area savarage, distally based sural flap in better choices for covering deformities of soft tissue surrounding heel and distal tibia. Keywords: Sural flap, Lateral supramalleolar flap, Soft tissue defect.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.